Literature DB >> 25241106

Comparison of two natural surfactants for pulmonary hemorrhage in very low-birth-weight infants: a randomized controlled trial.

Şenol Bozdağ1, Dilek Dilli2, Tülin Gökmen3, Uğur Dilmen4.   

Abstract

OBJECTIVE: To compare the efficacy of two natural surfactants for pulmonary hemorrhage in very low-birth-weight (VLBW) infants. STUDY
DESIGN: A prospective randomized controlled trial was conducted on 42 infants who were divided into two groups, poractant alfa (n = 21) and beractant (n = 21).
RESULTS: In both the groups, the mean standard deviation (SD) birth-weight and gestational age were similar (p = 0.33 and 0.89, respectively). Although, the mean oxygenation index (OI) increased after pulmonary hemorrhage compared with baseline value and decreased after surfactant in both groups, variations in OI were more prominent in poractant alfa group (before hemorrhage: 11.9, after hemorrhage: 22.7, 1 hour of surfactant: 14.6, 8th hour of surfactant: 7.8, 24th hour of surfactant: 8.5, p = 0.007 vs. before pulmonary hemorrhage:11.1, after pulmonary hemorrhage: 17.9, 1 hour of surfactant: 12.8, 8th hour of surfactant: 12.8, 24th hour of surfactant: 9.7, p = 0.02). There was no significant difference between the groups for OI values at all time points (p > 0.05). The rates of bronchopulmonary dysplasia (BPD) and mortality related to pulmonary hemorrhage were similar in both the groups.
CONCLUSION: Both natural surfactants improved oxygenation when administered for pulmonary hemorrhage in VLBW infants. The type of surfactant seems to have no effect on BPD and mortality rates in these patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241106     DOI: 10.1055/s-0034-1389090

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  6 in total

1.  [Risk factors for neonatal pulmonary hemorrhage in the neonatal intensive care unit of a municipal hospital].

Authors:  Jie Fan; Ming-Yan Hei; Xi-Lin Huang; Xiao-Ping Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-03

2.  Pulmonary Hemorrhage (PH) in Extremely Low Birth Weight (ELBW) Infants: Successful Treatment with Surfactant.

Authors:  Pradeep Suryawanshi; Rema Nagpal; Vaibhav Meshram; Nandini Malshe; Vijay Kalrao
Journal:  J Clin Diagn Res       Date:  2015-03-01

Review 3.  Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.

Authors:  Neetu Singh; Henry L Halliday; Timothy P Stevens; Gautham Suresh; Roger Soll; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

4.  Eligibility Criteria and Representativeness of Randomized Clinical Trials That Include Infants Born Extremely Premature: A Systematic Review.

Authors:  Leeann R Pavlek; Brian K Rivera; Charles V Smith; Joanie Randle; Cory Hanlon; Kristi Small; Edward F Bell; Matthew A Rysavy; Sara Conroy; Carl H Backes
Journal:  J Pediatr       Date:  2021-04-21       Impact factor: 6.314

5.  Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial.

Authors:  Bita Najafian; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Niloofar Nikjoo; Sobhan Amin; Majid Shohrati
Journal:  Contemp Clin Trials Commun       Date:  2016-04-13

6.  Perinatal risk factors for pulmonary hemorrhage in extremely low-birth-weight infants.

Authors:  Ting-Ting Wang; Ming Zhou; Xue-Feng Hu; Jiang-Qin Liu
Journal:  World J Pediatr       Date:  2019-11-04       Impact factor: 2.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.